Abstract:BACKGROUND: Hypoxia-inducible factor-1 alpha (HIF-1 alpha) plays an important role in tumour progression and metastasis through activation of many target genes that are especially involved in pivotal aspects of cancer biology. However, the prognostic role of HIF-1 alpha has been controversial in primary patients with lung cancer. This meta-analysis was performed to systematically evaluate whether HIF-1 alpha expression is associated with the clinical outcomes in lung cancer patients.METHODS: We retrieved relevant articles from Cochrane library, PubMed, EMbase, CNKI, CBM, VIP and Wan Fang Databases from inception to May 2012. Studies were selected using specific inclusion and exclusion criteria. A systematic review and meta-analysis was performed on the association between HIF-1 alpha expression and clinical outcomes in lung cancer patients. All analyses were performed using the Revman 5.1 software.RESULTS: A total of 30 studies were identified as eligible for the systematic review and meta-analysis. The expression of HIF-1 alpha was significantly higher than those in normal lung tissue; and III-IV stage, lymph node metastasis, poorly differentiation, squamous cell carcinoma and small cell lung cancer (SCLC) were significantly higher than those in I-II stage, no lymph node metastasis, well differentiation, adenocarcinomas and non small cell lung cancer (NSCLC), respectively (odds ratio (OR) = 19.00, 95% confidence interval (CI):12.12-29.78, p<0.00001; OR = 0.23, 95% CI:0.14-0.36, p<0.00001; OR = 3.72, 95% CI:2.38-5.80, p<0.00001; OR = 0.47, 95% CI:0.31-0.70, p<0.00002, OR = 0.24, 95% CI:0.07-0.77, p = 0.02; OR = 0.78, 95% CI:0.63-0.98, p = 0.03). VEGF and CA IX positive expression in HIF-1 alpha positive tumour tissues were significantly higher than those in HIF-1 alpha negative tumour tissues, respectively (OR = 3.23, 95% CI: 1.90-5.46, p<0.0001; OR = 3.84, 95% CI: 2.10-7.03, p<0.0001). The positive HIF-1 alpha tumour tissues of patients had lower 5-year survival rates (OR = 0.13, 95% CI: 0.03-0.47, p = 0.002) and overall survival (relative risk (RR) = 1.68, 95% CI: 1.12-2.50, p = 0.01).CONCLUSIONS: HIF-1 alpha is related to a differing degree of lung cancer cell, lymph node metastasis, post-operative survival time and histology (NSCLC vs. SCLC, adenocarcinomas vs. squamous cell carcinoma). HIF-1 alpha, which combines other proteins, such as vascular endothelial growth factor (VEGF) or CA IX, might serve as important parameters in evaluating biological behaviour and prognosis of lung cancer; it will be of benefit to clinical treatment and prognostic evaluation.

HIF1α and HIF2α Regulate Non-Small-cell Lung Cancer Dedifferentiation Via Expression of Sox2 and Oct4 under Hypoxic Conditions.

Oxia Inducible Factor 1α and Hypoxia Inducible Factor 2α Distinct and Functionally Overlapping Roles in R L Squamous Cell Carcinoma

Expression of hypoxia inducible factor-1α in non-small cell lung cancer

Hypoxia differently regulates the proportion of ALDHhi cells in lung squamous carcinoma H520 and adenocarcinoma A549 cells via the Wnt/β‐catenin pathway

Two-Stage Induced Differentiation of Oct4(+)/Nanog(+) Stem-Like Cells in Lung Adenocarcinoma

The effects of HIF-1alpha on gene expression profiles of NCI-H446 human small cell lung cancer cells

HIF-1α Mediates Functional Switching of TGF-Β Signaling by Regulating the PKM Mrna Splicing and Metabolic Reprogramming in Non-Small Cell Lung Cancer

miR‐495 and miR‐5688 are down‐regulated in non‐small cell lung cancer under hypoxia to maintain interleukin‐11 expression

HIF-1 and HIF-2 Play Distinct and Functionally Overlapping Roles in Oral Squamous Cell Carcinoma

Hypoxia Inducible Factor 1 Alpha And Hypoxia Inducible Factor 2 Alpha Play Distinct And Functionally Overlapping Roles In Oral Squamous Cell Carcinoma

Alternatively Expressed Transcripts Analysis of Non-Small Cell Lung Cancer Cells under Different Hypoxic Microenvironment.

Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma

Role of hypoxia-inducible factor-1α in the regulation of programmed death ligand 1 expression in lung adenocarcinoma

Reprogramming hematopoietic stem cell metabolism in lung cancer: glycolysis, oxidative phosphorylation, and the role of 2-DG

Expression and Pathological Mechanism of MMP-9 and HIF-2α in CD133 + Lung Cancer Stem Cells

Profiling of Genes Differentially Expressed After Targeted Inactivation of OCT4 Pluripotent Transcription Factor in Human Lung Adenocarcinoma Stem Cells

Glycine Decarboxylase and HIF-1α Expression Are Negative Prognostic Factors in Primary Resected Early-Stage Non-Small Cell Lung Cancer

The Expression Of Hypoxia-Inducible Factor-1 Alpha And Its Clinical Significance In Lung Cancer: A Systematic Review And Meta-Analysis

Hypoxia-Inducible Factor-1 Alpha Blocks Differentiation of Malignant Gliomas

Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy

The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells